MICROLINE SURGICAL, INC.
BEVERLY, MA

Microline Surgical, Inc., founded in 1987, is a wholly owned subsidiary of HOYA Corporation based in Tokyo, Japan. The company specializes in designing, developing, manufacturing, and marketing a comprehensive range of minimally invasive reusable surgical instruments globally. The product portfolio includes cutting-edge instruments for cutting, dissecting, grasping, cauterizing, and ligating used across various laparoscopic surgical disciplines such as General Surgery, Gynecologic Surgery, Urologic Surgery, and Bariatric Surgical procedures. All products have received FDA clearance and CE marking. Microline's flagship MiFusion product line features Starion instruments that utilize patented Thermal Fusion technology to seal and divide soft tissue effectively using direct heat and pressure. These versatile and reliable instruments are used worldwide for a variety of surgical applications, including Cardiac, Gynecological, General Surgery, Otolaryngology, and Urology procedures. The Microline Group is strategically positioned in the minimally invasive surgery market, estimated at $4 billion globally, with an opportunity focused on approximately $900 million. The company distributes its products internationally through over 70 independent distributors across key regions like the U.S., Europe, Japan, the Middle-East, and Asia, capitalizing on its relationship with HOYA to leverage sales offices in selected Asian territories. Notably, Microline has secured three contracts with leading Group Purchase Organizations in the U.S. Investing over 8% of its revenue into R&D, Microline leverages a team of highly skilled engineers developing products at its state-of-the-art proprietary research facility. The company's robust patent portfolio and ongoing investment in intellectual property underscore its innovative capabilities in laparoscopic surgical instruments. With a global workforce of 185, the headquarters are located over 50,000 sq ft at Beverly, Massachusetts. Committed to quality and regulatory compliance, Microline Surgical Inc.'s ISO 13485:2003 certification reflects adherence to stringent standards. U.S. Food and Drug Administration (FDA) and European Notified Body SGS audits ensure products meet international safety and performance criteria, facilitating CE marking in the European Union. Microline Surgical Inc. strives to design innovative minimally invasive surgical instruments that meet or exceed customer and professional expectations, maintaining a commitment to its quality management system and regulatory compliance as outlined by their official Quality Policy.